Entity Details

Primary name LAMA2
Entity type gene
Source Source Link

Details

PrimaryID3908
RefseqGeneNG_008678
SymbolLAMA2
Namelaminin subunit alpha 2
Chromosome6
Location6q22.33
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1995-02-02
ModificationDate2021-06-13

Ontological Relatives

UniProt IDsLAMA2_HUMAN

GO terms

Show/Hide Table
GOName
GO:0005102 signaling receptor binding
GO:0005198 structural molecule activity
GO:0005201 extracellular matrix structural constituent
GO:0005576 extracellular region
GO:0005604 basement membrane
GO:0007155 cell adhesion
GO:0007411 axon guidance
GO:0007517 muscle organ development
GO:0009887 animal organ morphogenesis
GO:0009888 tissue development
GO:0014037 Schwann cell differentiation
GO:0030155 regulation of cell adhesion
GO:0030198 extracellular matrix organization
GO:0030334 regulation of cell migration
GO:0031594 neuromuscular junction
GO:0032224 positive regulation of synaptic transmission, cholinergic
GO:0035633 maintenance of blood-brain barrier
GO:0042383 sarcolemma
GO:0043083 synaptic cleft
GO:0043197 dendritic spine
GO:0045995 regulation of embryonic development
GO:0062023 collagen-containing extracellular matrix

Diseases

Show/Hide Table
Disease IDSourceNameDescription
607855 OMIMMerosin-deficient congenital muscular dystrophy 1A (MDC1A)Characterized by difficulty walking, hypotonia, proximal weakness, hyporeflexia, and white matter hypodensity on MRI. The disease is caused by variants affecting the gene represented in this entry.
618138 OMIMMuscular dystrophy, limb-girdle, autosomal recessive 23 (LGMDR23)A form of autosomal recessive limb-girdle muscular dystrophy, a myopathy characterized by proximal and/or distal muscle weakness and atrophy. The age at onset is variable and can range from the first to the sixth decade, although later onset is less common. LGMDR23 is characterized by slowly progressive proximal muscle weakness primarily affecting the lower limbs, increased serum creatine kinase, dystrophic features, gait difficulties, and white matter abnormalities on brain imaging. Age at onset generally ranges from childhood to mid-adulthood. Some patients may have additional neurologic features, including executive deficits, seizures, and peripheral neuropathy. The disease is caused by variants affecting the gene represented in this entry.

Interactions

16 interactions